Related Experiment Video

Updated: Aug 11, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

Management of cardiovascular risk factors in type 2 diabetic patients undergoing coronary angiography

Lexin Wang1, Jingtian Li, Shukai Song

  • 1School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW2678, Australia. lwang@csu.edu.au

Croatian Medical Journal
|December 4, 2003
PubMed

Insights

Diabetic patients undergoing coronary angiography often have poorly controlled cardiovascular risk factors like high blood sugar and LDL cholesterol. Severe coronary artery disease is linked to higher levels of these risk factors.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Type 2 diabetes is a significant risk factor for cardiovascular disease.
  • Diabetic patients undergoing coronary angiography represent a high-risk population for adverse cardiac events.
  • Effective management of cardiovascular risk factors is crucial in this patient group.

Purpose of the Study:

  • To assess the prevalence and control of key cardiovascular risk factors in type 2 diabetic patients scheduled for coronary angiography.
  • To identify associations between cardiovascular risk factor levels and the severity of coronary artery disease.

Main Methods:

  • A cohort of 284 type 2 diabetic patients undergoing coronary angiography was analyzed.
  • Cardiovascular risk factors including Hemoglobin (Hgb) A1c, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), blood pressure (BP), and body mass index (BMI) were measured.
  • Severity of coronary artery disease was assessed during angiography.

Main Results:

  • Coronary artery disease (CAD) was prevalent, identified in 82.0% of patients.
  • Mean HgbA1c was 9.7%, with suboptimal control observed for LDL-C, BP, and BMI in a majority of patients.
  • Only 9.1% of patients achieved optimal control of all assessed cardiac risk factors.
  • Higher average LDL-C, triglycerides, and blood pressure were significantly associated with severe CAD compared to moderate-to-mild CAD (p<0.01).

Conclusions:

  • Cardiovascular risk factors are inadequately controlled in the majority of type 2 diabetic patients undergoing coronary angiography.
  • Poor control of LDL-C, triglycerides, and blood pressure is linked to more severe coronary artery disease.
  • Intensified risk factor management strategies are warranted in this high-risk diabetic population.
Abstract

More Related Videos

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...